Catalent Inc. CTLT

NYS: CTLT | ISIN: US1488061029   17/12/2024
63,48 USD (0,00%)
(0,00%)   17/12/2024
Grafiek Catalent Inc. Grafiek Catalent Inc.

Catalent Inc. in het nieuws

18 april 2024 · SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX · Persbericht

15 april 2023 · CATALENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT · Persbericht

14 april 2023 · CTLT Investors Have Opportunity to Lead Catalent, Inc. Securities Fraud Lawsuit · Persbericht

24 maart 2023 · CTLT Investors Have Opportunity to Lead Catalent, Inc. Securities Fraud Lawsuit · Persbericht

18 maart 2023 · CATALENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT · Persbericht

11 maart 2023 · CATALENT SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Catalent To Contact Him Directly To Discuss Their Options · Persbericht

28 februari 2023 · Bronstein, Gewirtz & Grossman, LLC Notifies Catalent, Inc. (CTLT) Investors of Class Action and to Actively Participate · Persbericht

9 januari 2023 · Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement · Persbericht

30 augustus 2021 · Highlander Partners Announces the Signing of a Definitive Agreement to Sell Bettera Brands to Catalent · Persbericht

Profiel Catalent Inc.

Fabricage van farmaceutische preparaten
Farmaceutische producten: Andere
Gezondheidstechnologie
Productie

CEO: Alessandro Maselli

Werknemers: 11.908

Mijn selecties